Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Saady Kohanim"'
The purpose of this study was to determine whether the Bcr-Abl tyrosine kinase can be assessed by γ-imaging using an 111In-labeled anti-phosphotyrosine (APT) antibody, and if the response to treatment with imatinib could be detected using this imagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5512fb21793016f5a1a3acd529b63980
https://doi.org/10.1158/1535-7163.c.6531533
https://doi.org/10.1158/1535-7163.c.6531533
Supplementary Video from Molecular imaging of Bcr-Abl phosphokinase in a xenograft model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ba949584be1d4e6ba05636c7bc4ce5
https://doi.org/10.1158/1535-7163.22484690
https://doi.org/10.1158/1535-7163.22484690
Publikováno v:
Molecular Cancer Therapeutics. 8:703-710
The purpose of this study was to determine whether the Bcr-Abl tyrosine kinase can be assessed by γ-imaging using an 111In-labeled anti-phosphotyrosine (APT) antibody, and if the response to treatment with imatinib could be detected using this imagi
Autor:
Dong Fang Yu, Hiroaki Kurihara, Saady Kohanim, David J. Yang, William D. Erwin, Richard Mendez, E. Edmund Kim, Massimo Cristofanilli
Publikováno v:
Applied Radiation and Isotopes. 66:1175-1182
Early detection of cellular events is important to predict the outcome of the patients. This study was aimed to use (99m)Tc EC-annexin V to image tumor cells undergoing apoptosis.In 10 patients with breast cancer, scintigraphic images and dosimetric
Autor:
Nobukazu Takahashi, E. Edmund Kim, Saady Kohanim, David J. Yang, Agatha Borne, Chang Sok Oh, Hiroaki Kurihara, Osama Mawlawi
Publikováno v:
Academic Radiology. 14:1050-1057
Rationale and Objectives Endometriosis is a common women’s health problem. Animal models provide an invaluable tool to study the natural history of endometriosis. We previously have reported that 99mTc-labeled glutamate peptide-estradiol (99mTc-GAP
Autor:
Dong Fang Yu, Hiroaki Kurihara, Ali Azhdarinia, Nobukazu Takahashi, Joe Y. Chang, E. Edmund Kim, Chang Sok Oh, Xiaochun Zhang, Saady Kohanim, David J. Yang
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 34:354-362
To evaluate the feasibility of using (99m)Tc-glutamate peptide-estradiol in functional imaging of estrogen receptor-positive [ER(+)] diseases.3-Aminoethyl estradiol (EDL) was conjugated to glutamate peptide (GAP) to yield GAP-EDL. Cellular uptake stu
Autor:
Megumi Ito, Thomas Yang, Saady Kohanim, Jerry Bryant, Chang Sok Oh, Ali Azhdarinia, Vincenzo K. Wong, E. Edmund Kim, Kaoru Ozaki, Allison C. Greenwell, David J. Yang
Publikováno v:
Pharmaceutical Research. 22:1471-1479
DNA markers are useful in assessing cell proliferation. The purpose of this study was to synthesize (99m)Tc-ethylenedicysteine-guanine (EC-Guan) for evaluation of cell proliferation.Tumor cells were incubated with (99m)Tc-EC-Guan for cell cycle analy
Autor:
Chang-Sok Oh, David J. Yang, Dong Fang Yu, Ali Azhdarinia, Jerry Bryant, Richard Mendez, E. Edmund Kim, Saady Kohanim
Publikováno v:
Pharmaceutical Research. 22:776-783
To evaluate the feasibility of regional radiochemotherapy of mammary tumors using in situ hydrogel loaded with cisplatin (CDDP) and rhenium-188 ((188)Re).Sodium alginate (SA) and calcium chloride were used to create a hydrogel for delivery of CDDP an
Autor:
Chang Guhn Kim, E. Edmund Kim, Donald A. Podoloff, Megumi Ito, Masashi Yukihiro, David J. Yang, Ali Azhdarinia, Saady Kohanim, Chang Sok Oh, Dong Fang Yu, Jerry Bryant
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 19:443-456
The aim of this study was to evaluate 99mTc-ethylenedicysteine-glucosamine (EC-DG) for the assessment of tumor growth.To evaluate whether 99mTc-EC-DG is involved in cell nuclei activity, in vitro thymidine incorporation, and cell-cycle assays of EC-D
Autor:
David Yang, Masashi Yukihiro, Dong-Fang Yu, Megumi Ito, Chang-Sok Oh, Saady Kohanim, Ali Azhdarinia, Chang-Guhn Kim, Jerry Bryant, E. Edmund Kim, Donald Podoloff
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 19:443-456